High Mark Wealth Management LLC Zymeworks Inc. Transaction History

High Mark Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	BUY	$27.35 - $37.28 $1,367 - $1,864	50 Added 21.74%	280 $8,000
Q2 2021 Aug 02, 2021	SELL	$26.5 - $38.23 $503 - $726	-19 Reduced 7.63%	230 $8,000
Q1 2021 Apr 22, 2021	SELL	$29.83 - $56.81 $4,086 - $7,782	-137 Reduced 35.49%	249 $8,000
Q4 2020 Jan 27, 2021	SELL	$39.12 - $54.99 $49,134 - $69,067	-1,256 Reduced 76.49%	386 $18,000
Q3 2020 Oct 26, 2020	BUY	$29.21 - $46.58 $34,029 - $54,265	1,165 Added 244.23%	1,642 $76,000
Q2 2020 Jul 22, 2020	BUY	$33.67 - $40.0 $16,060 - $19,080	477 New	477 $17,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $906M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.